SCHEMBL5598443

SCHEMBL5598443

CCC[C]O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510394 0.77
SCHEMBL5427300 0.74
SCHEMBL129173 0.69
SCHEMBL111751 0.67
Methyl Alcohol SCHEMBL29055878 0.67
Methane SCHEMBL8910474 0.67
Charcoal, Activated SCHEMBL30358619 0.67
SCHEMBL6291054 0.67
SCHEMBL23045692 0.64
SCHEMBL5167647 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160009703-A1 BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERIDINE OR PIPERAZINE DERIVATIVES AND PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THEREOF LIAONING EMMY BIOLOGICAL PHARMACEUTICAL CO., LTD (CN) 2016-01-14 US claimed
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2015-10-22 US claimed
EP-0996671-B1 NUCLEATING AGENTS FOR POLYHYDROXYALKANOATES AND OTHER THERMOPLASTIC POLYESTERS AND METHODS FOR THEIR PRODUCTION AND USE METABOLIX INC (US) 2004-12-01 EP claimed
EP-0786018-B1 CORROSION INHIBITING COMPOSITIONS GREAT LAKES CHEMICAL EUROP (CH) 2002-01-09 EP claimed
EP-0996671-A1 NUCLEATING AGENTS FOR POLYHYDROXYALKANOATES AND OTHER THERMOPLASTIC POLYESTERS AND METHODS FOR THEIR PRODUCTION AND USE MONSANTO COMPANY (US) 2000-05-03 EP claimed
EP-0934326-A1 SUBSTITUTED AMINOALKANE PHOSPHONIC ACIDS Novartis AG (CH) 1999-08-11 EP claimed
WO-1999005208-A1 NUCLEATING AGENTS FOR POLYHYDROXYALKANOATES AND OTHER THERMOPLASTIC POLYESTERS AND METHODS FOR THEIR PRODUCTION AND USE MONSANTO COMPANY (US) 1999-02-04 WO claimed
WO-1998017672-A1 SUBSTITUTED AMINOALKANE PHOSPHONIC ACIDS NOVARTIS AG (CH) 1998-04-30 WO claimed
US-20220160617-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2022-05-26 US disclosed
US-20210386802-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-12-16 US disclosed
US-9415047-B2 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2016-08-16 US disclosed
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2015-10-22 US disclosed
WO-2007095711-A1 BIODEGRADABLE POLYMERIC COMPOSITION AND METHOD FOR PRODUCING A BIODEGRADABLE POLYMERIC COMPOSITION PHB INDUSTRIAL S.A. (BR) 2007-08-30 WO disclosed
US-20060287257-A1 Pharmaceutical compositions to treat diseases caused by mycobacterium STOCKEL RICHARD F 2006-12-21 US disclosed
WO-1999005208-A1 NUCLEATING AGENTS FOR POLYHYDROXYALKANOATES AND OTHER THERMOPLASTIC POLYESTERS AND METHODS FOR THEIR PRODUCTION AND USE MONSANTO COMPANY (US) 1999-02-04 WO disclosed
EP-0886521-A1 TOPICAL BISPHOSPHONATES FOR PREVENTION OF BONE RESORPTION Binderman, Itzhak (IL) 1998-12-30 EP disclosed
WO-1997029754-A1 TOPICAL BISPHOSPHONATES FOR PREVENTION OF BONE RESORPTION BINDERMAN ITZHAK (IL) 1997-08-21 WO disclosed
US-4735959-A HYPOGLYCEMIC AGENTS DR. KARL THOMAE GMBH (DE) 1988-04-05 US disclosed
EP-0058779-B1 CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES Dr. Karl Thomae GmbH (DE) 1984-09-19 EP disclosed
EP-0058779-A2 Carboxamides, their preparation and their use as medicines Dr. Karl Thomae GmbH (DE) 1982-09-01 EP disclosed